Regeneron reports first quarter 2025 financial and operating results

Tarrytown, n.y., april 29, 2025 (globe newswire) -- regeneron pharmaceuticals, inc. (nasdaq: regn) today announced financial results for the first quarter of 2025 and provided a business update.

REGN Ratings Summary

REGN Quant Ranking